Clinical Research Directory
Browse clinical research sites, groups, and studies.
A Research Study Looking Into Blood Levels of the Medicine NNC0487-0111 in the Body and How Well it is Tolerated in People With Reduced Liver Function and Normal Liver Function
Sponsor: Novo Nordisk A/S
Summary
The study is testing a new study medicine to treat people with overweight/obesity and type 2 diabetes. The aim of this study is to see if it is safe and to find out how it works in people with reduced liver function and people with normal liver function.
Official title: A Study Investigating the Pharmacokinetic Properties, Safety and Tolerability of NNC0487-0111 in Participants With Various Degrees of Hepatic Impairment and Participants With Normal Hepatic Function
Key Details
Gender
All
Age Range
18 Years - 80 Years
Study Type
INTERVENTIONAL
Enrollment
35
Start Date
2026-05-13
Completion Date
2027-12-01
Last Updated
2026-05-14
Healthy Volunteers
No
Conditions
Interventions
NNC0487-0111
NNC0487-0111 will be administered subcutaneously using PDS290 pre-filled pen-injectors in a skinfold in the thigh.
Locations (2)
Summit Clinical Research s.r.o.
Bratislava, Slovakia
Summit Clinical Research s.r.o.
Malacky, Slovakia